344 related articles for article (PubMed ID: 12890744)
21. WIF1, an inhibitor of the Wnt pathway, is rearranged in salivary gland tumors.
Queimado L; Lopes CS; Reis AM
Genes Chromosomes Cancer; 2007 Mar; 46(3):215-25. PubMed ID: 17171686
[TBL] [Abstract][Full Text] [Related]
22. Alterations of the INK4a-ARF gene locus in pleomorphic adenoma of the parotid gland.
Weber A; Langhanki L; Schütz A; Wittekind C; Bootz F; Tannapfel A
J Pathol; 2002 Nov; 198(3):326-34. PubMed ID: 12375265
[TBL] [Abstract][Full Text] [Related]
23. Expression and mutations of p53 in salivary gland tumours.
Kärjä VJ; Syrjänen KJ; Kurvinen AK; Syrjänen SM
J Oral Pathol Med; 1997 May; 26(5):217-23. PubMed ID: 9178173
[TBL] [Abstract][Full Text] [Related]
24. Assessment of p63 expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and basal cell and canalicular adenomas.
Edwards PC; Bhuiya T; Kelsch RD
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 May; 97(5):613-9. PubMed ID: 15153875
[TBL] [Abstract][Full Text] [Related]
25. Vascular endothelial growth factor (VEGF) expression and microvascular density in salivary gland tumours.
Faur AC; Lazar E; Cornianu M
APMIS; 2014 May; 122(5):418-26. PubMed ID: 23937241
[TBL] [Abstract][Full Text] [Related]
26. Genetic analysis of the human oncoprotein MDM2 in benign and malignant tumors of the salivary gland.
Schlott T; Nagel H; Laskawi R; Eiffert H; Droese M
Pathobiology; 2001; 69(2):67-76. PubMed ID: 11752900
[TBL] [Abstract][Full Text] [Related]
27. Frequent expression of HAGE in presentation chronic myeloid leukaemias.
Adams SP; Sahota SS; Mijovic A; Czepulkowski B; Padua RA; Mufti GJ; Guinn BA
Leukemia; 2002 Nov; 16(11):2238-42. PubMed ID: 12399967
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical detection of E-cadherin in certain types of salivary gland tumours.
Andreadis D; Epivatianos A; Mireas G; Nomikos A; Poulopoulos A; Yiotakis J; Barbatis C
J Laryngol Otol; 2006 Apr; 120(4):298-304. PubMed ID: 16623973
[TBL] [Abstract][Full Text] [Related]
29. Different gene expression of MDM2, GAGE-1, -2 and FHIT in hepatocellular carcinoma and focal nodular hyperplasia.
Schlott T; Ahrens K; Ruschenburg I; Reimer S; Hartmann H; Droese M
Br J Cancer; 1999 Apr; 80(1-2):73-8. PubMed ID: 10389981
[TBL] [Abstract][Full Text] [Related]
30. CK7+/CK20- immunoexpression profile is typical of salivary gland neoplasia.
Meer S; Altini M
Histopathology; 2007 Jul; 51(1):26-32. PubMed ID: 17593078
[TBL] [Abstract][Full Text] [Related]
31. p63 expression in salivary gland tumors: role of DeltaNp73L in neoplastic transformation.
Foschini MP; Gaiba A; Cocchi R; Pennesi MG; Pession A
Int J Surg Pathol; 2005 Oct; 13(4):329-35. PubMed ID: 16273188
[TBL] [Abstract][Full Text] [Related]
32. Tumours of the lacrimal gland. Epidemiological, clinical and genetic characteristics.
von Holstein SL
Acta Ophthalmol; 2013 Nov; 91 Thesis 6():1-28. PubMed ID: 24893972
[TBL] [Abstract][Full Text] [Related]
33. STAT3 expression in salivary gland tumours.
de Araújo VC; Furuse C; Cury PR; Altemani A; de Araújo NS
Oral Oncol; 2008 May; 44(5):439-45. PubMed ID: 17826306
[TBL] [Abstract][Full Text] [Related]
34. A microRNA signature for the differential diagnosis of salivary gland tumors.
Denaro M; Navari E; Ugolini C; Seccia V; Donati V; Casani AP; Basolo F
PLoS One; 2019; 14(1):e0210968. PubMed ID: 30682201
[TBL] [Abstract][Full Text] [Related]
35. Impaired FHIT expression characterizes serous ovarian carcinoma.
Ozaki K; Enomoto T; Yoshino K; Fujita M; Buzard GS; Kawano K; Yamasaki M; Murata Y
Br J Cancer; 2001 Jul; 85(2):247-54. PubMed ID: 11461085
[TBL] [Abstract][Full Text] [Related]
36. Tumours of the salivary glands in northeastern China: a retrospective study of 2508 patients.
Wang XD; Meng LJ; Hou TT; Huang SH
Br J Oral Maxillofac Surg; 2015 Feb; 53(2):132-7. PubMed ID: 25457627
[TBL] [Abstract][Full Text] [Related]
37. Implications of methylation patterns of cancer genes in salivary gland tumors.
Williams MD; Chakravarti N; Kies MS; Maruya S; Myers JN; Haviland JC; Weber RS; Lotan R; El-Naggar AK
Clin Cancer Res; 2006 Dec; 12(24):7353-8. PubMed ID: 17189407
[TBL] [Abstract][Full Text] [Related]
38. The expression of MAGE and GAGE genes in uterine cervical carcinoma of Korea by RT-PCR with common primers.
Chang HK; Park J; Kim W; Kim K; Lee M; Park U; Choi B
Gynecol Oncol; 2005 May; 97(2):342-7. PubMed ID: 15863128
[TBL] [Abstract][Full Text] [Related]
39. Expression of the MAGE-1, -2, -3, -4, and -6 genes in non-squamous cell carcinoma lesions of the head and neck.
Lee KD; Eura M; Ogi K; Nakano K; Chikamatsu K; Masuyama K; Ishikawa T
Acta Otolaryngol; 1996 Jul; 116(4):633-9. PubMed ID: 8831854
[TBL] [Abstract][Full Text] [Related]
40. Salivary gland tumours: 25 years of experience from a single institution in Croatia.
Lukšić I; Virag M; Manojlović S; Macan D
J Craniomaxillofac Surg; 2012 Apr; 40(3):e75-81. PubMed ID: 21641811
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
